
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ioana Agache, Susanne Lau, Cezmi A. Akdiş, et al.
Allergy (2019) Vol. 74, Iss. 5, pp. 855-873
Open Access | Times Cited: 245
Showing 1-25 of 245 citing articles:
Allergic rhinitis
Jean Bousquet, Josep M. Antó, Claus Bachert, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 600
Jean Bousquet, Josep M. Antó, Claus Bachert, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 600
Allergen Immunotherapy in Children User’s Guide
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 269
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 269
EAACI Biologicals Guidelines—Recommendations for severe asthma
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 14-44
Open Access | Times Cited: 219
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 14-44
Open Access | Times Cited: 219
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 197
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 197
Role of IL‐25, IL‐33, and TSLP in triggering united airway diseases toward type 2 inflammation
Haiyu Hong, Shumin Liao, Fenghong Chen, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2794-2804
Open Access | Times Cited: 179
Haiyu Hong, Shumin Liao, Fenghong Chen, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2794-2804
Open Access | Times Cited: 179
Advances and recent developments in asthma in 2020
Lacin Cevhertas, İsmail Öğülür, Debbie J. Maurer, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3124-3146
Open Access | Times Cited: 149
Lacin Cevhertas, İsmail Öğülür, Debbie J. Maurer, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3124-3146
Open Access | Times Cited: 149
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 139
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 139
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
The impact of formaldehyde exposure on lung inflammatory disorders: Insights into asthma, bronchitis, and pulmonary fibrosis
Asif Ahmad Bhat, Muhammad Afzal, Ahsas Goyal, et al.
Chemico-Biological Interactions (2024) Vol. 394, pp. 111002-111002
Open Access | Times Cited: 22
Asif Ahmad Bhat, Muhammad Afzal, Ahsas Goyal, et al.
Chemico-Biological Interactions (2024) Vol. 394, pp. 111002-111002
Open Access | Times Cited: 22
Perspectives in allergen immunotherapy: 2019 and beyond
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 130
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 130
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
Ioana Agache, Claudio Rocha, Jessica Beltrán, et al.
Allergy (2020) Vol. 75, Iss. 5, pp. 1043-1057
Open Access | Times Cited: 119
Ioana Agache, Claudio Rocha, Jessica Beltrán, et al.
Allergy (2020) Vol. 75, Iss. 5, pp. 1043-1057
Open Access | Times Cited: 119
Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy
Yin Yao, Cailing Chen, Di Yu, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 456-470
Open Access | Times Cited: 107
Yin Yao, Cailing Chen, Di Yu, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 456-470
Open Access | Times Cited: 107
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
Alessandra Vultaggio, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2764-2774
Open Access | Times Cited: 97
Alessandra Vultaggio, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2764-2774
Open Access | Times Cited: 97
Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens
Mohamed H. Shamji, Janice A. Layhadi, Hanisah Sharif, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1769-1778
Closed Access | Times Cited: 74
Mohamed H. Shamji, Janice A. Layhadi, Hanisah Sharif, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1769-1778
Closed Access | Times Cited: 74
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Allergen Immunotherapy in Asthma
Kazuyuki Nakagome, Makoto Nagata
Pathogens (2021) Vol. 10, Iss. 11, pp. 1406-1406
Open Access | Times Cited: 64
Kazuyuki Nakagome, Makoto Nagata
Pathogens (2021) Vol. 10, Iss. 11, pp. 1406-1406
Open Access | Times Cited: 64
Dermatophagoides pteronyssinus allergen Der p 22: Cloning, expression, IgE ‐binding in asthmatic children, and immunogenicity
Ying Zhou, Lin Li, Zhiwei Yu, et al.
Pediatric Allergy and Immunology (2022) Vol. 33, Iss. 8
Closed Access | Times Cited: 59
Ying Zhou, Lin Li, Zhiwei Yu, et al.
Pediatric Allergy and Immunology (2022) Vol. 33, Iss. 8
Closed Access | Times Cited: 59
Dysregulation of the epithelial barrier by environmental and other exogenous factors
Yasutaka Mitamura, İsmail Öğülür, Yağız Pat, et al.
Contact Dermatitis (2021) Vol. 85, Iss. 6, pp. 615-626
Open Access | Times Cited: 57
Yasutaka Mitamura, İsmail Öğülür, Yağız Pat, et al.
Contact Dermatitis (2021) Vol. 85, Iss. 6, pp. 615-626
Open Access | Times Cited: 57
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Mariana Farraia, Inês Paciência, Francisca de Castro Mendes, et al.
Allergy (2022) Vol. 77, Iss. 6, pp. 1719-1735
Open Access | Times Cited: 53
Allergen immunotherapy for long-term tolerance and prevention
Martín Penagos, Stephen R. Durham
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 3, pp. 802-811
Closed Access | Times Cited: 42
Martín Penagos, Stephen R. Durham
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 3, pp. 802-811
Closed Access | Times Cited: 42
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial
Christian Woehlk, Sangeetha Ramu, Asger Sverrild, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 9, pp. 1161-1170
Open Access | Times Cited: 39
Christian Woehlk, Sangeetha Ramu, Asger Sverrild, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 9, pp. 1161-1170
Open Access | Times Cited: 39
Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
House dust mite SCIT reduces asthma risk and significantly improves long‐term rhinitis and asthma control—A RWE study
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1042-1051
Open Access | Times Cited: 11
Marek Jutel, Ludger Klimek, Hartmut Richter, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 1042-1051
Open Access | Times Cited: 11
30 years of sublingual immunotherapy
Giovanni Passalacqua, Diego Bagnasco, Giorgio Walter Canonica
Allergy (2019) Vol. 75, Iss. 5, pp. 1107-1120
Open Access | Times Cited: 64
Giovanni Passalacqua, Diego Bagnasco, Giorgio Walter Canonica
Allergy (2019) Vol. 75, Iss. 5, pp. 1107-1120
Open Access | Times Cited: 64